Evidence map›Paper›PMID 36064536›Full record

ArticleJournal of geriatric oncology2022

Older patients' experiences following initial diagnosis of acute myeloid leukemia: A qualitative study.

Maya Abdallah, Sindhuja Kadambi, Meghana Parsi, Maitreyee Rai, Jason H Mendler, Marsha Wittink, Paul R Duberstein, Mazie Tsang, Heidi D Klepin, Kah Poh Loh

Abstract read
In one paragraph

Article in Journal of geriatric oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maya AbdallahSection of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA, United States of America. Electronic address: maya.abdallah@bmc.org.
Sindhuja KadambiDivision of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States of America. Electronic address: sindhuja_kadambi@urmc.rochester.edu.
Meghana ParsiMD Anderson Cancer Center at Cooper University Hospital, Camden, NJ, United States of America. Electronic address: parsi-meghana@cooperhealth.edu.
Maitreyee RaiDivision of Hematology and Medical Oncology, Allegheny Health Network, Pittsburgh, PA, United States of America.
Jason H MendlerDivision of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States of America. Electronic address: jason_mendler@urmc.rochester.edu.
Marsha WittinkDepartments of Psychiatry and Family Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America. Electronic address: marsha_wittink@urmc.rochester.edu.
Paul R DubersteinRutgers School of Public Health, Piscataway, NJ, United States of America. Electronic address: paul.duberstein@rutgers.edu.
Mazie TsangUniversity of California, San Francisco, CA, United States of America. Electronic address: mazie.tsang@ucsf.edu.
Heidi D KlepinWake Forest Baptist Comprehensive Cancer Center, Medical Center Blvd, Winston-Salem, NC, United States of America. Electronic address: hklepin@wakehealth.edu.
Kah Poh LohDivision of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States of America. Electronic address: kahpoh_loh@urmc.rochester.edu.

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
Geriatric Oncology Research Infrastructure to Improve Clinical CareR33AG059206 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WILLIAM DALE, Heidi Diana Klepin · 2020 to 2026
$5.1M
A novel mobile health exercise intervention for older patients with myeloid neoplasmsR00CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2021 to 2023
$747k
A Novel Mobile Health Exercise Intervention for Older Patients with Myeloid NeoplasmsK99CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2019 to 2020
$385k
Epigenetic markers, functional status, and exercise in older adults with myeloid neoplasmsR03AG073985 · NIA · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2022 to 2023
$308k
NCI NIH HHS K99 CA237744NCI NIH HHS R00 CA237744NCI NIH HHS UG1 CA189961NIA NIH HHS R03 AG073985NIA NIH HHS R33 AG059206
6 · The paper itself

Abstract

introductionThe onset of symptoms and the diagnosis of acute myeloid leukemia (AML) often occur suddenly and may lead to a range of emotional responses. Understanding patients' experiences and emotional states allows clinicians to tailor care to patients' needs. Previous studies have largely focused on patients' experiences at diagnosis and after remission has been achieved among those who received intensive chemotherapy. In this study, we evaluated experiences of older patients with AML who had received or were receiving treatments of varying intensity, in both outpatient and inpatient settings, and who were at different stages in their treatment course at the time of our interviews. MATERIALS AND

methodsWe conducted a single center qualitative study which aimed to understand factors influencing older patients' treatment decision-making and the findings were previously reported. This analysis specifically explored older patients' experiences at various stages after AML diagnosis. We purposively sampled patients based on treatment intensity and stage of treatment (undergoing induction treatment, post-remission treatment, or post-allogeneic hematopoietic stem cell transplant). We recruited fifteen patients aged ≥60 years with AML. The sample size was determined based on reaching data saturation for the primary study aim. For this analysis, data saturation was reached by the fourteenth manuscript. In-depth semi-structured interviews that had been recorded and transcribed were re-analyzed using inductive thematic analysis to explore patients' experiences. Coding was performed using Atlas.ti. We identified themes with the aim of capturing the most commonly shared experiences.

resultsMean age of the fifteen patients was 72.1 years; all had received one or more treatments including intensive induction therapy (10/15), lower-intensity treatment (7/15), and/or hematopoietic stem cell transplant (3/15). Patients experienced strong negative emotional responses, including shock, that were barriers to processing information and meaningful communication. Patients also shared their perspectives on communication with healthcare professionals (including thoughts on adequacy of information provided) and coping strategies. DISCUSSION: Understanding older patients' experiences, including emotional responses and barriers to communication and decision making, at AML diagnosis and throughout the illness trajectory allows clinicians to address patients' supportive care needs during this difficult period.

Indexed as

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteAgedCommunicationEmotionsHumansQualitative ResearchAcute myeloid leukemiaGeriatric hematologyOlder adultsPatient experience

Identifiers

PMID36064536
PMCPMC9982634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.